Daily Market Updates: AstraZeneca explores deal talks with Bristol Myers Squibb

Global Markets

Home›Global Markets›Europe›AstraZeneca explores deal talks with Bristol Myers Squ…

AstraZeneca explores deal talks with Bristol Myers Squibb

The reported preliminary discussions have rekindled expectations for Big Pharma consolidation and have moved AstraZeneca shares.

Reported · Written up by our desk · Europe

CNBC Markets reports that AstraZeneca is in preliminary talks that could lead to a broader deal with Bristol Myers Squibb.

The report said the prospect of the transaction has reignited debate about whether large pharmaceutical companies need to consolidate to expand scale, particularly in the U.S.

According to the coverage, the deal discussion also moved shares, reflecting investor focus on potential combination activity in Big Pharma.

← Newer storyRBI holds repo rate, USD/INR slips to around 95.10 Older story →TS Lombard urges investors to favor 10-year gilts over US Treasurys

More like this

Global MarketsUK construction PMI stabilizes despite dismal underlying sentiment

Global MarketsBerger Paints sees competitive pressure but expects stronger Q2

Global MarketsGoogle weighs frontier AI vs commercial priorities as AI talent exits

Global MarketsUK chancellor faces early test on borrowing to fund public investment

Global MarketsGoogle reshuffles AI leadership as Jeff Dean exits and Demis Hassabis steps down

Sources

CNBC MarketsAstraZeneca may buck a decade of pharma strategy to buy U.S. scale

CNBC WorldAstraZeneca may buck a decade of pharma strategy to buy U.S. scale

Global Markets

AstraZeneca explores deal talks with Bristol Myers Squibb

More like this

Sources

Get the close, explained.